Open: 2.38 Close: 2.3 Change: -0.08

Today's Summary

Spero Therapeutics co-founder Ankit Mahadevia, MD resigned from its Board of Directors, its Development Committee, and all officer and director roles at its subsidiaries, citing other professional commitments. The company expressed gratitude for his service since inception. Spero Therapeutics is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and MDR bacterial infections with high unmet need.